PubMed · 15107834
HPV E6 proteins interact with specific PML isoforms and allow distinctions to be made between different POD structures.
Abstract
Mucosal human papillomaviruses (HPVs) are the causative agents of a number of human pathologies, including benign condylomas, as well as of the majority of cervical cancers and their high-grade precursor lesions. Although the viral E6 protein is known to be essential for driving malignant progression of HPV-infected cells, there are still many uncertainties about its mode of action. In this study, we have analysed the intracellular distribution of the E6 oncoproteins from the high-risk HPV-18 and the low-risk HPV-11. We show that both E6 proteins localize within the nucleus in nuclear bodies that are confocal with the promyelocytic leukaemia (PML) protein. Using a panel of different PML isoforms, we demonstrate specific co-localization between the E6 proteins and PML isoforms I-IV, but not with PML isoforms V and VI. We also demonstrate the interaction between E6 and a subset of PML isoforms in vivo. As a consequence of this interaction, the insoluble form of PML IV is destabilized by HPV-18 E6 through a proteasome-dependent pathway. Interestingly, both HPV-11 E6 and HPV-18 E6 can readily overcome PML IV-induced cellular senescence in primary cells. These results show separable functions for different PML isoforms that are specifically targeted by the HPV E6 oncoproteins.
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
Ernesto Guccione, Katherine J Lethbridge, Neil Killick, Keith N Leppard, Lawrence Banks. 2004-06-10. HPV E6 proteins interact with specific PML isoforms and allow distinctions to be made between different POD structures.. https://doi.org/10.1038/sj.onc.1207631
Cite the original work for its findings. Save a collection to share your selection of sources.